Bausch + Lomb Corporation (BLCO)
After hours:
| Previous close | 15.41 |
| Open | 15.41 |
| Bid | 15.15 x 1000 |
| Ask | 15.78 x 1400 |
| Day's range | 15.36 - 15.57 |
| 52-week range | 14.37 - 21.95 |
| Volume | |
| Avg. volume | 377,959 |
| Market cap | 5.421B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.59 |
| Earnings date | 20 Feb 2024 - 26 Feb 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 29.37 |
Simply Wall St.Is Bausch + Lomb Corporation (NYSE:BLCO) Trading At A 39% Discount?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Bausch + Lomb fair value estimate is US$25.50 Current share...
Business WireBausch + Lomb Reports More Than 76 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs
VAUGHAN, Ontario, November 15, 2023--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its exclusive ONE by ONE and Biotrue Eye Care Recycling programs have collected a total of 76,645,000 million units, or 464,100 pounds, of used contact lenses, eye care and lens care materials in the United States, which is equivalent to the weight of 140 hippos1.
Business WireBausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 Guidance
VAUGHAN, Ontario, November 01, 2023--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its third-quarter 2023 financial results.
